Embryonic ectoderm development pseudogene 1 (EEDP1)

EED pseudogene 1 is classified as a pseudogene, indicating that it is a segment of DNA resembling the functional EED gene (embryonic ectoderm development) but lacks protein-coding ability due to disabling mutations or sequence disruptions[2][3]. Pseudogenes like EEDP1 may arise from gene duplication or retrotransposition of mRNA, resulting in sequences with similarity to parental genes but no active protein product[1][3]. Although pseudogenes have long been considered nonfunctional, there is increasing evidence that some can act as regulators—for instance, by acting as miRNA sponges, thereby influencing the expression of their parental genes or related targets[1][3]. However, there is no specific evidence in the literature that EEDP1 itself acts as a therapeutic target, disease biomarker, or pharmacologic receptor/enzyme; neither are there approved drugs that directly act on EEDP1, nor is it a validated clinical or therapeutic target. Its primary role in molecular biology may be limited to regulatory RNA and genetic architecture, rather than direct effector or target activity in disease or therapy[1][4][2]. EED pseudogene 1 is not a canonical therapeutic target, is not associated with a known disease mechanism requiring pharmacologic intervention, and its inclusion as a target would be considered incorrect for therapeutic or receptor/effector classification.

Other names

EEDP1Embryonic ectoderm development pseudogene 1Embryonic ectoderm development pseudogene, EEDP1